Cynata Therapeutics Limited has released a press release.
Board, Management Changes, Expenditure Reductions, RDTI Loan
Earlier from Cynata Therapeutics
- Reinstatement to Official Quotation
- CYP-001 GvHD Trial Primary Evaluation Results
- Suspension from Quotation
- EU Positive Opinion on CYP-001 Paediatric Investigation Plan